Lab Data’s New Role as the Backbone of AI-Driven Clinical Trials
Learn how research and development labs can leverage AI to transform laboratory data into actionable insights
Inside the Diagnostics Industry-dtet
‘Full Speed Ahead’ with Test Results? Not So Fast
Lab scientists using testing equipment too quickly brings up training concerns in discussions at recent ADLM conference
A 21st Century Response to the Cures Act
Patients’ unfettered access to complex test results can lead to confusion and distress—but generative AI can help.
Inside the Diagnostics Industry: New Government BRCA Test Guidelines Are a Mixed Bag for Genetic Testing Labs
From - Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…
Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test
...
Already a member? Log in here
Search Intensifies for Markers for Prosthetic Joint Infection
...
Already a member? Log in here
Partnerships, IT Solutions Improve Infectious Disease Diagnostic Stewardship
From - Diagnostic Testing & Emerging Technologies
Appropriate use of testing is becoming a greater challenge, given the growing number of available diagnostic tests and their increasing complexity&…
The Practice of Early Gestational Diabetes Screening Evaluated
...
Already a member? Log in here
Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies
From - Diagnostic Testing & Emerging Technologies
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last…
Evidence Suggests Need for Expanded HCV Testing, Particularly Coupled With Opioid Screening in Young People
From - Diagnostic Testing & Emerging Technologies
Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic…
PAMA Unlocks Golden Age for Innovative Diagnostics
By Chance Scott bio
The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition…
Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry
From - Diagnostic Testing & Emerging Technologies
For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine…
New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending
From - Diagnostic Testing & Emerging Technologies
As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by…